Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial

Overview of attention for article published in European Heart Journal, December 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

So far, Altmetric has seen 3 public wall posts from 2 users.

#PublicaSalutIB Stents alliberadors d'anfilimus vs. zotarolimus en pacients amb DM i MAC https://buff.ly/3GK3kYB

#PublicaSalutIB Stents alliberadors d'anfilimus versus zotarolimus en pacients amb DM i MAC https://buff.ly/3GK3kYB

#PubSaludMurcia Amphilimus- versus zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease (SUG…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.